N-(4-(2-Hydrazinyl-2-oxoethoxy)phenyl)acetamide

Catalog No. :
ACCGYS351
CAS No. :
75129-75-8
Molecular Formula :
C10H13N3O3
Molecular Weight :
223.23

IUPAC Name:N-(4-(2-hydrazineyl-2-oxoethoxy)phenyl)acetamide

N-(4-(2-Hydrazinyl-2-oxoethoxy)phenyl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$65.00Login to see priceIn stockInquiry
250mg97%$111.00Login to see priceIn stockInquiry
1g97%$317.00Login to see priceIn stockInquiry
5g97%$1268.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(4-(2-Hydrazinyl-2-oxoethoxy)phenyl)acetamide
IUPAC NameN-(4-(2-hydrazineyl-2-oxoethoxy)phenyl)acetamide
MDL No.MFCD00245968
Molecular FormulaC10H13N3O3
Molecular Weight223.23
SMILESO=C(NN)COC1=CC=C(NC(C)=O)C=C1
InChI KeyUKZKIIKNIOGTIA-UHFFFAOYSA-N
SynonymN-[4-(2-hydrazino-2-oxoethoxy)phenyl]acetamide;Acetic acid, 2-[4-(acetylamino)phenoxy]-, hydrazide;N-(4-(2-hydrazinyl-2-oxoethoxy)phenyl)acetamide
CAS No.75129-75-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H312-H315-H319-H332-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACCGYS351 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCGYS351 route product structure diagram
    ACCGYS35175129-75-8 In Stock
Inquiry

2. ACCGYS351 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCGYS351 route product structure diagram
    ACCGYS35175129-75-8 In Stock
Inquiry

Comments (0)